Revvity | PKI - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Agilent USD 2.29B 20M 2026-06
Align Technology USD 1.91B 2.74M 2026-06
Bio Techne USD 163.7M 10.42M 2026-06
Bio-Rad Laboratories USD 961.3M 44.3M 2026-06
Bruker USD 1.2B 150.4M 2026-06
Celltrion KRW 292.71B 9.09B 2026-03
Charles River Laboratories USD 1.13B 41.04M 2026-06
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Danaher USD 8.1B 645M 2026-06
Dentsply International USD 1.18B 22M 2026-06
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 34.39M 3.89M 2026-06
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Illumina USD 1.58B 12M 2026-06
Intuitive Surgical USD 2.58B 65.1M 2026-06
IQVIA Holdings USD 8.82B 486M 2026-06
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Laboratory Of America USD 2.12B 516.4M 2026-06
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Mesa Laboratories USD 54.4M 6.1M 2025-12
Mettler Toledo International USD 1.2B 92.14M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
OraSure Technologies USD 25.12M 18.96M 2026-06
Organigram Holdings CAD 88.74M 5.31M 2026-03
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pacific Biosciences Of California USD 68.81M 3.45M 2026-06
Pharma Mar EUR 98.42M 9.2M 2026-06
Qiagen NV USD 581.45M 102.34M 2026-06
Quest Diagnostics USD 1.79B 389M 2026-06
Quidel USD 993.4M 31M 2026-06
Repligen USD 132.66M 6.45M 2026-06
Revvity USD 1.28B 37.71M 2026-06
Sartorius EUR 1.44B 668.7M 2026-06
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Tilray USD 259.32M 8.32M 2025-09
Waters USD 2.27B 1.03B 2026-03
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 3.02B 742.54M 2026-06